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Introduction
Mid-regional pro-adrenomedullin (MR-proADM) is a
fragment of 48 amino acids which splits from the final
proADM molecule in a ratio of 1:1 with ADM. It is essen-
tially irrelevant, but proportionally represents the levels
and activity of ADM. Its half-life is several hours longer,
and its plasma concentrations can be determined in clini-
cal practice. It has been identified as a prognostic marker,
stratifying the mortality risk in patients with sepsis.
Objectives
To evaluate the usefulness of MR-proadrenomedullin
(MR-proADM) levels in the diagnosis and prognosis of
sepsis in patients admitted to the ICU.
Methods
Prospective observational single-center study. A total of
120 consecutive patients with suspected severe sepsis were
recruited to the ICU of Jerez Hospital. Epidemiological,
clinical, laboratory data and MR-proADM, Procalcitonin
(PCT), and C-reactive protein (CRP) levels were collected
at the time of admission, at 48 hours, at the 5th day and
on the day of discharge from the ICU.
Results
104 patients were diagnosed at discharge of severe sep-
sis and 16 patients were diagnosed of SIRS without
sepsis. The group of septic patients reached MR-
proADM levels of 4.05 nmol/l vs of 0.309 nmol/l in
not septic patients (p < 0.0001). The AUC-ROC was
0.9474 (Figure 1).
At 48 hours after admission the MR-proADM levels in
surviving septic patients fell to 1.65 nmol/l and in the
non-survivors 2.475 nmol/l (p = 0.04). On the 5th day
following admission the survivor levels fell to
1.36 nmol/l vs 3.42 nmol/l in the septic patients who
died in the ICU (p = 0.0006). At the 5th day the survi-
vors showed greater clearance MR-proADM with a
median level of 62.7% vs 21.2% in the non-survivors
(Table 1).
The AUC the ROC curve at the 5th day was: MR-
proADM 0,828(p = 0,001); PCT 0.725 (p = 0,016) CRP
0.700 (p = 0,0214). The AUC the ROC curve to MR-
proADM clearance at the 5th day was 0,734 (p =
0,0104) (Figure 2)
Patients with MR-proADM levels of 2.5 nmol/l and
above or MR-proADM clearance less than 30% at the
5th day following admission in the ICU showed an
enhance in mortality (p < 0.0001). In the multivariate
analysis (Cox proportional hazards models) MR-
proADM levels and MR-proADM clearance at the 5th
day following admission, were statistically significant
predictive factors for mortality in the ICU and at 90
days (Figure 3).
Conclusions
Initial MR-proADM levels help to identify the infectious
origin in patients with SIRS and organ dysfunction. MR-
proADM levels and its clearance at the 5th day follow-
ing admission are the most effective biomarker to deter-
mine unfavorable evolution and the risk of mortality in
patients with severe sepsis admitted to the ICU.
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Figure 1 ROC curve MR proADM sepsis diagnosis.
Table 1 MR-ADM levels and clearance in survival subgroups
SEPTIC SURVIVORS SEPTIC SURVIVORS SEPTIC NON SURVIVORS SEPTIC NON SURVIVORS
MR-proADM median IQR median IQR p
ADMISSION levels (nmol/l 3.04 1.67-6.8 5.7 1.81-7.79 p = 0.263
48 HOURS levels (nmol/l 1.65 1.11-3.62 2.47 1.43-6.48 p = 0.04
5TH DAY levels (nmol/l 1.36 0.88-1.96 3.42 2.18-10.57 p = 0.0006
DISCHARGE levels (nmol/l) 1.268 0.88-1.78
48 HOURS Clearance (%) 43.2 14.4-60.5 22.8 -1.3-59.72 p = 0.20
5TH DAY Clearance (%) 62.7 46.17-82.3 21.2 -38.7-61 p = 0.015
Figure 2 ROC curves Biomarker 5th day prognosis.
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Figure 3 multivariate analysis mortality 90 days.
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